Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)

Saturday, March 14, 2026 · holzer & holzer

AI Briefing

Investors in BlackRock TCP Capital Corp. (TCPC) shares have until April 6, 2026, to seek to be appointed lead plaintiff in a class action lawsuit.
Investors in Mereo BioPharma Group plc (MREO) shares have until April 6, 2026, to seek to be appointed lead plaintiff in a class action lawsuit.
Investors in POMDOCTOR LIMITED (POM) shares have until April 6, 2026, to seek to be appointed lead plaintiff in a class action lawsuit.